Amendment to Development and Manufacturing Terms and ConditionsDevelopment and Manufacturing Terms and Conditions • November 10th, 2014 • Newlink Genetics Corp • Pharmaceutical preparations • New York
This Amendment to Development and Manufacturing Terms and Conditions (this “Amendment”) is made and entered into as of September 30, 2014 by and among NewLink Genetics Corporation, a Delaware corporation (“Customer”), and WuXi AppTec, Inc., a Delaware corporation (“WuXi AppTec,” and collectively with the Customer, the “Parties”).
